Most Recent
Otsuka can press ahead with ‘inconsistent’ defences in Abilify patent dispute
Intellectual Property 2019-02-27 8:38 pm By Miklos Bolza

Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Aft goes on the offensive, files lawsuit over new Maxigesic ads
Competition & Consumer Protection 2019-02-26 2:04 pm By Cat Fredenburgh

AFT Pharmaceuticals has filed a lawsuit seeking to pre-empt competitor Reckitt Benckiser from pursuing a lawsuit against it over recent ads for its painkiller Maxigesic. […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Ramsay Health denies anti-competitive conduct over failed day surgery
Competition & Consumer Protection 2019-02-25 9:17 pm By Miklos Bolza

Ramsay Health Care has denied its conduct towards a group of surgeons seeking to open a rival clinic in Coffs Harbour, NSW was anti-competitive or […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

‘Misconceived’ Sanofi appeal over injector pen patent gets shot down by Full Court
Intellectual Property 2019-02-25 1:34 pm By Cat Fredenburgh

The Full Court has denied a request by Sanofi that it review a judge’s refusal to block Alphapharm from listing its Semglee insulin injector pen […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

ACCC intent on proving misuse of market power claims in Ramsay Health trial
Trials 2019-02-22 11:19 pm By Cat Fredenburgh

The stakes will be high for the ACCC when the trial kicks off Monday in its case against Ramsay Health Care alleging the hospital giant […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Fisher & Paykel, ResMed lay down swords in global patent dispute
Intellectual Property 2019-02-22 1:00 pm By Cat Fredenburgh

New Zealand-based medical device maker Fisher & Paykel and US-based ResMed have agreed to resolve all disputes between them over patents for devices used to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Calgary CFO convicted for misstating company revenue
Healthcare 2019-02-20 10:20 pm By Cat Fredenburgh

The former chief financial officer for Calvary Health Care has been convicted and sentenced after pleading guilty to making false records that misstated the company’s revenue […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Court to issue speedy ruling on Sanofi’s second stab at injector pen injunction
Intellectual Property 2019-02-20 9:48 pm By Cat Fredenburgh

The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi’s challenge to a judge’s refusal to block Alphapharm from listing an […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Sandoz ordered to pay Lundbeck over $26.3M for infringing Lexapro patent
Intellectual Property 2019-02-19 10:18 pm By Christine Caulfield

Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Neurim wins fight to amend patent for top-selling Circadin amid infringement case
Intellectual Property 2019-02-19 7:35 pm By Christine Caulfield

Drug maker Neurim Pharmaceuticals has won a bid to amend its Australian patent for top selling sleeping pill Circadin over the protests of two generic […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.